Skip to content
OpenCapital
Get started

Celldex Therapeutics CLDX Financed construction projects

Financed construction projects at other companies

Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$953K+89.1%
Calumet, Inc. logo
Calumet, Inc.CLMT
$29.8M+10.4%
Restoration Hardware logo
Restoration HardwareRH
$30.48M+88.4%
The GEO Group logo
The GEO GroupGEO
$2.05M-11.3%
AXT
AXTAXTI
$137K—
Acadia Realty Trust logo
Acadia Realty TrustAKR
$11.32M—

Other financials

Income statement

See full
Revenue$15.0K-97.8%
Operating income-$84.4M-34.6%
Net income-$78.7M-46.3%
EPS (diluted)-$1.18-45.7%

Balance sheet

See full
Cash & equivalents$35.7M+109%
Total debt$1.9M-44.3%
Total equity$456.2M-35.1%
Total assets$511.3M-30.9%

Cash flow

See full
Operating cash flow-$65.6M-20.6%
CapEx$1.6M+518%
Free cash flow-$67.2M-23.0%

Valuation

See full
Market cap$2.59B+75.2%
Enterprise value$2.55B+74.4%
P/S2,989.2×+2,794×

Profitability

See full
Operating margin-35,688.5%-39,114pp
Net margin-32,753.6%-35,519pp
FCF margin-26,125.8%-28,907pp

Returns & leverage

See full
Return on equity-48.9%-498pp
Debt / equity0×0.0×
Current ratio8.9×-12.7×

Where this comes from

Reported directly by Celldex Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid.

The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celldex Therapeutics's financed construction projects.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celldex Therapeutics's financed construction projects?
Celldex Therapeutics (CLDX) reported financed construction projects of $953K in Q1 2026.
How has Celldex Therapeutics's financed construction projects changed year-over-year?
Celldex Therapeutics's financed construction projects increased by 89.1% year-over-year, from $504K to $953K.
What does financed construction projects mean?
This metric tracks capital expenditures related to construction projects that have been incurred but remain unpaid at the end of the reporting period. It serves as a supplemental indicator of future cash outflows required to settle obligations for property, plant, and equipment development. Monitoring this helps investors assess near-term liquidity needs and the pace of capital asset expansion.